WEKO3
アイテム
Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer.
https://repo.qst.go.jp/records/48598
https://repo.qst.go.jp/records/485981f42995b-c7fb-4675-a89d-d086986ec03c
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-03-19 | |||||
タイトル | ||||||
タイトル | Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Isozaki, Yuka
× Isozaki, Yuka× Yamada, Shigeru× Kawashiro, Shohei× Yasuda, Shigeo× Okada, Naomi× Ebner, Daniel× Tsuji, Hiroshi× Kamada, Tadashi× 磯崎 由佳× 山田 滋× 川城 壮平× 安田 茂雄× 岡田 直美× エブナー ダニエル× 辻 比呂志× 鎌田 正 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | BACKGROUND: The safety and effectiveness of carbon-ion radiotherapy (CIRT) for isolated para-aortic lymph node (PALN) metastasis was evaluated retrospectively. METHODS: CIRT for isolated PALN metastasis from CRC was performed in 34 cases from June 2006 to August 2015 in our institute. A median dose of 52.8 Gy(RBE) (range, 48-52.8 Gy(RBE)) was delivered with a median daily dose of 4.4 Gy(RBE) (range, 4.0-4.4 Gy(RBE)). RESULTS: The median follow-up duration for all patients was 24.4 months (range, 7-82.8 months). There were 13 cases (38.2%) who achieved complete response after treatment. The local control rates at 2 and 3 years were 70.1% and 70.1%, respectively. The overall survival rates at 2 and 3 years were 83.3% and 63.0%, respectively. The 3-year survival rates for Stage I-III were 68.7%, while those for Stage IV was 0%. The overall survival of cases with rectal cancer or with high CA19-9 values pre-CIRT tended to be worse. The median survival period was 41.7 months. Twelve of the 34 patients survived for more than 3 years. There were no adverse effects of Grade 3 or higher. CONCLUSIONS: CIRT for isolated PALN recurrence after curative resection for CRC appears effective and safe, and it is considered a promising therapy. |
|||||
書誌情報 |
Journal of surgical oncology 巻 116, 号 7, p. 932-938, 発行日 2017-07 |
|||||
出版者 | ||||||
出版者 | Wiley | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0022-4790 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 28727901 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1002/jso.24757 |